Oracle Is Soaring After Blowout Earnings. 3 Reasons to Buy the Stock (and 1 Reason to Avoid It).

Oracle guided to $67B in revenue for FY2026 and $90B for FY2027 (a 34.3% increase) after Q3 results that saw cloud revenue rise 44% YoY and cloud now >50% of sales; shares jumped 9.2% on March 11. The company exited the quarter with $553B in RPO and reported AI capacity gross margins of 32% (above 30% guidance) and $29B of new contracts using a BYOH/upfront model. However, leverage is a material concern: notes payable and other non-current borrowings totaled $124.72B (up 41.6% YoY), and only $30B of a announced $50B financing program has been raised (the $20B ATM equity remains unfilled).

Analysis

Oracle’s headline growth narrative masks a two-speed P&L: operating leverage from backlog conversion will lift reported revenue and gross margins, but cash-flow convertibility is throttled by financing structure and contract economics. The shift to bring-your-own-hardware and upfront payments reduces Oracle’s capital intensity but increases counterparty and receivable concentration — that makes revenue growth stickier on paper while shifting most balance-sheet and timing risk onto large customers and their suppliers.

The clearest second-order beneficiaries are infrastructure vendors and system integrators: sustained enterprise GPU/CPU procurement cycles favor Nvidia and Intel but also create a multi-quarter cadence of hardware tightness and OEM pricing power that can re-rate supplier margins faster than cloud gross margins improve. Conversely, any materially higher-for-longer rate or a marked widening of Oracle’s funding spreads would convert headline revenue growth into an equity-value trap as earnings get absorbed by financing costs.

Catalysts to watch in the next 3–12 months: pace of at‑the‑market equity issuance (dilution and signaling), quarterly disclosure on cash conversion of backlog (FCF guides), and OEM supply/pricing updates (Nvidia/Intel dealer restocking). The consensus is polarized — investors are either celebrating revenue momentum or fearing leverage — so trades that isolate infra demand exposure or buy cheap downside protection on Oracle are higher-expected-value than an unhedged long in the stock.

Key Decisions for Investors

• Long NVDA calls (9-month ATM): size 1–2% portfolio. Rationale: direct beneficiary of enterprise GPU demand driven by large cloud customers; max loss = premium, skewed upside (2–4x) if enterprise ramp persists over next 6–12 months.
• Oracle equity with protection (buy ORCL stock + buy 12‑month put ~10% OTM): size 2–3% portfolio. Rationale: captures backlog-to-revenue upside while capping headline downside from a balance-sheet shock; cost = put premium, payoff preserves upside through 12 months.
• Tail hedge on Oracle (buy 18‑24 month deep OTM ORCL puts): size 0.5–1% portfolio. Rationale: Cheap insurance against a deleveraging or funding-stress event that would materially reset equity value; small premium, asymmetric payoff in credit-driven downside scenarios.
• Long INTC 12–18 month calls (LEAPS): size 1% portfolio. Rationale: play subtle share-shift/price recovery if enterprise demand broadens and Intel captures non-GPU CPU spend; risk = premium, reward = >2x conditional on multi-quarter capacity tightness and design wins.